GILEAD SCIENCES, INC.
SEC insider (Form 3/4/5 filer). CIK 0000882095. 10% Owner at ASSEMBLY BIOSCIENCES, INC. (ASMB) and 2 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on May 26, 2026. Located in FOSTER CITY, CA.
Companies GILEAD SCIENCES, INC. has filed insider reports for
- ASSEMBLY BIOSCIENCES, INC. (ASMB): 10% Owner
- Xilio Therapeutics, Inc. (XLO): 10% Owner
- Arcus Biosciences, Inc. (RCUS): 10% Owner
GILEAD SCIENCES, INC.
CIK: 0000882095
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- May 26, 2026ASMB
ASSEMBLY BIOSCIENCES, INC.
AwardDirect471.7K shares at avg. $26.50$12.5M - Feb 13, 2026XLO
Xilio Therapeutics, Inc.
PurchaseDirectPrefunded Warrants (right to buy)
3.7M shares at avg. $0.53- - Nov 26, 2025XLO
Xilio Therapeutics, Inc.
In-the-MoneyDirectSeries B Warrants (right to buy)
13.3M shares- - Nov 26, 2025XLO
Xilio Therapeutics, Inc.
In-the-MoneyDirectPrefunded Warrants (right to buy)
13.3M shares at avg. $0.75- - Aug 8, 2025ASMB
ASSEMBLY BIOSCIENCES, INC.
PurchaseDirect2.3M shares- - Jun 5, 2025XLO
Xilio Therapeutics, Inc.
PurchaseDirectSeries C Warrants (right to buy)
13.3M shares- - Jun 5, 2025XLO
Xilio Therapeutics, Inc.
PurchaseDirectPrefunded Warrants (right to buy)
13.3M shares- - Jun 5, 2025XLO
Xilio Therapeutics, Inc.
PurchaseDirectSeries A Warrants (right to buy)
13.3M shares- - Jun 5, 2025XLO
Xilio Therapeutics, Inc.
PurchaseDirectSeries B Warrants (right to buy)
13.3M shares- - Feb 18, 2025RCUS
Arcus Biosciences, Inc.
PurchaseDirect1.4M shares at avg. $11.00$15.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 26, 2026 |  ASMB ASSEMBLY BIOSCIENCES, INC. | Award | 471,698 | $26.50 | $12,499,997 | Direct |
| Feb 13, 2026 |  XLO Xilio Therapeutics, Inc. | Purchase Prefunded Warrants (right to buy) | 3,739,000 | $0.53 | - | Direct |
| Nov 26, 2025 | XLO Xilio Therapeutics, Inc. | In-the-Money Series B Warrants (right to buy) | 13,335,000 | - | - | Direct |
| Nov 26, 2025 | XLO Xilio Therapeutics, Inc. | In-the-Money Prefunded Warrants (right to buy) | 13,335,000 | $0.75 | - | Direct |
| Aug 8, 2025 | ASMB ASSEMBLY BIOSCIENCES, INC. | Purchase | 2,295,920 | - | - | Direct |
| Jun 5, 2025 | XLO Xilio Therapeutics, Inc. | Purchase Series C Warrants (right to buy) | 13,335,000 | - | - | Direct |
| Jun 5, 2025 | XLO Xilio Therapeutics, Inc. | Purchase Prefunded Warrants (right to buy) | 13,335,000 | - | - | Direct |
| Jun 5, 2025 | XLO Xilio Therapeutics, Inc. | Purchase Series A Warrants (right to buy) | 13,335,000 | - | - | Direct |
| Jun 5, 2025 | XLO Xilio Therapeutics, Inc. | Purchase Series B Warrants (right to buy) | 13,335,000 | - | - | Direct |
| Feb 18, 2025 |  RCUS Arcus Biosciences, Inc. | Purchase | 1,363,636 | $11.00 | $14,999,996 | Direct |
1-10 of 12 transactions